40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-134.19%
Both yoy net incomes decline, with CRK at -122.05%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.75%
Some D&A expansion while CRK is negative at -100.00%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-82.16%
Negative yoy deferred tax while CRK stands at 121.82%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
81.45%
Slight usage while CRK is negative at -65.76%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
83.34%
Some yoy usage while CRK is negative at -66.52%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-1545.00%
Negative yoy while CRK is 7385.87%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
215.67%
Some CFO growth while CRK is negative at -40.28%. John Neff would note a short-term liquidity lead over the competitor.
-16.70%
Both yoy lines negative, with CRK at -70.83%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
42.47%
Acquisition growth of 42.47% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
23.58%
Purchases growth of 23.58% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
16.70%
Liquidation growth of 16.70% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-11.67%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-3.17%
Both yoy lines negative, with CRK at -58.65%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment growth of 100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-75.00%
Both yoy lines negative, with CRK at -63.17%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
44.06%
Buyback growth of 44.06% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.